MedPath

REFANI Pakistan study - effect of differing modalities of cash transfers on reducing the risk of wasting in children in Pakista

Not Applicable
Completed
Conditions
ow weight-for-height: Wasting or thinness indicates in most cases a recent and severe process of weight loss, which is often associated with acute starvation and/or severe disease.
Nutritional, Metabolic, Endocrine
Manutrition
Registration Number
ISRCTN10761532
Lead Sponsor
K Department for International Development (DFID)
Brief Summary

2015 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/26459336 protocol 2017 Results article in http://www.ncbi.nlm.nih.gov/pubmed/28542506 results 2018 Results article in https://doi.org/10.1093/heapol/czy045 cost, cost-efficiency and cost-effectiveness (added 25/04/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
5680
Inclusion Criteria

1. Households identified as poor and very poor (according to wealth index criteria) and with a child or children aged 6-48 months
2. Households with children born in the area during the study period

Exclusion Criteria

1. Poor and very poor households with no eligible child
2. Households with children who moved to the area within 6 months before the intervention (and may not be typical of households in the village e.g. those migrating due to drought in their area)
3. Households who do not give consent
4. Children who are chronically ill (with prescribed medical treatment)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of wasting (as measured by weight-for-height Z-score (WHZ) <-2 or the presence of bilateral pitting oedema) in children <5 years old, assessed at baseline and then monthly during the intervention period and then again at 1 year after baseline
Secondary Outcome Measures
NameTimeMethod
1. Severe wasting (defined as WHZ <-3 SD or oedema); mean WHZ <br>2. Low MUAC (children: <125mm & < 115mm, mothers: <230mm & <210mm) <br>3. Stunting (defined as height-for-age (HAZ) <2 SD; severe stunting <3 SD) <br>4. Anaemia (children and women); haemoglobin Hb g/dl(means)<br>5. Body Mass Index (BMI) (non PLW >19 years old) (<16, <17<18.5kg/m2)<br>6. Morbidity in children (diarrhoea, malaria and respiratory illness). <br>7. Individual Diet Diversity Score (children and mothers)<br>1-7 will be assessed at baseline and then monthly during the intervention period and then again at 1 year after baseline.<br>8. Cost effectiveness of the different cash transfer modalities, assessed at the end of the intervention
© Copyright 2025. All Rights Reserved by MedPath